Monkeypox plays rally as New York calls outbreak a public emergency

Monkeypox virus test results document

Bill Oxford/iStock via Getty Images

  • Companies focused on developing solutions against monkeypox jumped in the pre-market Monday after New York became the second major U.S. city to call the current outbreak a public health emergency.
  • Announcing the decision on Saturday, New York Mayor Eric Adams and Dr. Ashwin Vasan, commissioner of the city's health and mental hygiene department, said: "We estimate that approximately 150,000 New Yorkers may currently be at risk for monkeypox exposure."
  • On Thursday, San Francisco declared a state of emergency over the outbreak as the number of monkeypox cases there reached 28.
  • Notable gainers, Virax Biolabs Group (VRAX), GeoVax Labs (GOVX), and Tonix Pharmaceuticals (NASDAQ:TNXP) have added ~42%, ~52%, and ~21%, respectively, on heavy volumes. Others, including Chimerix (CMRX), Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), and Co-Diagnostics (CODX), are also trading higher.
  • Meanwhile, SIGA Technologies (SIGA), the maker of monkeypox therapeutic TPOXX, has added ~7% after a ~23% selloff on Friday.

Recommended For You

Comments (94)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.